Dan Coffin Joins Illuminas as Director of Illuminas Health
Illuminas welcomes Dan Coffin to its London office to lead a new global Healthcare practice. Dan has 14 years’ global market research experience, as well as domestic UK expertise. He formerly headed up Pharmaceuticals at Holden Pearmain, and was a Healthcare Director at Hall & Partners, Senior Executive at Isis Research, Marketing Executive at LifeScan & Senior Analyst at Roche Pharmaceuticals.
Dan and team will be working closely with clients to ensure research is effectively acted upon and drives better decisions. Dan has worked with a variety of leading pharmaceutical companies in areas such as phase 1 – 3 clinical and commercial development, marketing strategy, product launch, line extensions, market landscaping, treatment mapping and product opportunity analysis, as well as more high-end segmentation, pricing and conjoint based approaches.
John Connaughton, Illuminas CEO said “Dan fits perfectly with the Illuminas philosophy of offering bespoke, method-neutral solutions to solve complex business problems. It’s great to welcome someone with Dan’s sector experience to be able to apply our capabilities in high-end qual, quant and marketing sciences to the Healthcare sector.”